Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
Condition: Ulcerative Colitis Interventions: Drug: Tilpisertib Fosmecarbil; Drug: Placebo Sponsor: Gilead Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials